Therapeutic Human Polyclonals
Latest round
- Series B
Last raised
- Nov 2002
Total raised
- $5M
Investors
- 2
About Therapeutic Human Polyclonals
Therapeutic Human Polyclonals Inc.Therapeutic Human Polyclonals Inc. operates as a domain name brokerage, offering crucial digital branding services. The firm is headquartered in Mountain View, US.50 million, marking a pivotal moment in its corporate journey.com primarily offers domain names for sale, serving as an intermediary for clients seeking to acquire digital properties. The company's core product is the sale of domain names, which are essential for establishing an online presence, whether for personal branding, e-commerce, or corporate identity.com, which is offered at USD 1,795 or through flexible payment plans, the company addresses the need for unique web addresses that enhance visibility and accessibility in the digital domain. The platform caters to a diverse clientele, including entrepreneurs, small business owners, and established corporations, aiming to simplify the domain acquisition process while ensuring customer satisfaction.com revolves around direct sales of domain names, with options for immediate purchase or installment payment plans. The transaction structure is predominantly B2C, where individual customers or businesses purchase domain names through the website. The company emphasizes ease of access and quick delivery, typically providing domain access within one to two hours of purchase.Following its acquisition by Roche, Therapeutic Human Polyclonals Inc. plans to leverage this partnership to enhance its offerings in the domain name market. Although no new products are currently announced, the company anticipates expanding its reach into new markets in Asia and South America by 2008.
Who invested in Therapeutic Human Polyclonals
2 investors across 2 rounds
See all investors in Therapeutic Human Polyclonals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Therapeutic Human Polyclonals
Who invested in Therapeutic Human Polyclonals?
Therapeutic Human Polyclonals has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Therapeutic Human Polyclonals raised?
Therapeutic Human Polyclonals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Therapeutic Human Polyclonals last raise money?
Therapeutic Human Polyclonals's most recent round on record is a Series B, in Nov 2002.
What does Therapeutic Human Polyclonals do?
Therapeutic Human Polyclonals Inc.
Where is Therapeutic Human Polyclonals headquartered?
Therapeutic Human Polyclonals is headquartered in Mountain View, US.
Which VCs invest in companies like Therapeutic Human Polyclonals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Therapeutic Human Polyclonals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Therapeutic Human Polyclonals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.